Back to search results

A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine

Abroad (travel likely)RecruitingPHASE1

Conditions

Acute Treatment of Migraine

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Arkansas Children's Hospital, Little Rock, Arkansas, United States

  • Velocity Clinical Research, Washington DC, Washington D.C., District of Columbia, United States

  • Coastal Heritage Clinical Research, Hinesville, Georgia, United States

  • Clinical Research Institute, Minneapolis, Minnesota, United States

  • Children's Hospital & Medical Center, Omaha, Nebraska, United States

  • True North Neurology, Port Jefferson Station, New York, United States

  • Accellacare - Piedmont, Statesville, North Carolina, United States

  • Accellacare of Piedmont HealthCare, Statesville, North Carolina, United States

  • Accellacare US Inc., Winston-Salem, North Carolina, United States

  • Central States Research, Tulsa, Oklahoma, United States

  • Cedar Health Research, Dallas, Texas, United States

  • Wasatch Clinical Research, LLC, Salt Lake City, Utah, United States

  • Granger Medical Holladay - Holladay Clinic, Salt Lake City, Utah, United States

Study leads

  • Pfizer CT.gov Call Center

    Study Director

    Pfizer

View source on ClinicalTrials.gov(opens in a new tab)